Inhibition of human renal acid phosphatases by nephrotoxic micromolar concentrations of fluoride

Experimental and Toxicologic Pathology

Volumn 54, Issue 3, 2002, Pages 231-237

  Partanen, Seppo ^a  

^a JORVI HOSPITAL   (Finland)

Author keywords

Acid phosphatases; Fluoride; Human; Nephrotoxicity

Indexed keywords

ACID PHOSPHATASE; ALPHA NAPHTHYL PHOSPHATASE; FLUORIDE; GLYCEROL 2 PHOSPHATASE; PHOSPHATASE; TARTARIC ACID; UNCLASSIFIED DRUG; ENZYME INHIBITOR;

ARTERIOLE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; ENDOTHELIUM; ENZYME ACTIVITY; ENZYME INHIBITION; GLOMERULUS; HUMAN; HUMAN TISSUE; KIDNEY CIRCULATION; NEPHROTOXICITY; AGED; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; IN VITRO STUDY; KIDNEY; MIDDLE AGED; VASCULARIZATION;

GLOMERULUS;

ACID PHOSPHATASE; AGED; AGED, 80 AND OVER; ARTERIOLES; ENZYME INHIBITORS; FLUORIDES; HUMANS; KIDNEY; KIDNEY GLOMERULUS; MIDDLE AGED;

EID: 0036855908     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1078/0940-2993-00251     Document Type: Article

References (25)

1. Baykov AA, Alexandrov AP, Smirnova IN: A two-step mechanism of fluoride inhibition of rat liver inorganic pyrophosphatase. Arch Biochem Biophys 1992; 294: 238-243.
2. Cittanova ML, Lelongt B, Verpont MC, et al.: Fluoride ion toxicity in human kidney collecting duct cells. Anesthesiology 1996; 84: 428-435.
3. Cousins MJ, Mazze RI: Methoxyflurane nephrotoxicity: A study of dose response in man. JAMA 1973; 225: 1611-1616.
4. Farleay JR, Wergedal JE, Baylink DJ: Fluoride directly stimulates proliferation and alkaline phosphatase activity of bone-forming cells. Science 1983; 222: 330-332.
5. Fleming I, Busse R: Signal transduction of eNOS activation. Cardiovasc Res 1999; 43: 532-541.
6. Guha-Chowdhury N, Clark AG, Sissons CH: Inhibition of purified enolases from oral bacteria by fluoride. Oral Microbiol Immunol 1997; 12: 91-97.
7. Goldberg ME, Cantillo J, Larijani GE, et al.: Sevoflurane versus isoflurane for maintenance of anesthesia: Are serum inorganic fluoride ion concentrations of concern? Anesth Analg 1996; 82: 1268-1272.
8. Hellermann GR, Flam BR, Eichler DC, et al.: Stimulation of receptor-mediated nitric oxide production by vanadate. Arterioscler Thromb Vasc Biol 2000; 20: 2045-2050.
9. Higuchi H, Sumikura H, Sumita S, et al.: Renal function in patients with high serum fluoride concentrations after prolonged sevoflurane anesthesia. Anesthesiology 1995; 83:449-458.
10. Janokila AJ, Woodford TA, Lam K-W, et al.: Protein-tyrosine phosphatase activity of hairy cell tartrate-resistant acid phosphatase. Leukemia 1992; 6: 199-203.
11. Kharash ED, Hankins DC, Thummel KE: Human kidney methoxyflurane and sevoflurane metabolism. Intrarenal fluoride production as a possible mechanism of methoxyflurane nephrotoxicity. Anesthesiology 1995; 82:689-699.
12. Lundy MW, Lau KH, Blair HC, et al.: Chick osteoblasts contain fluoride-sensitive acid phosphatase activity. J Histochem Cytochem 1988; 36: 1175-1180.
13. Mazze RJ: Fluorinated anaesthetic nephrotoxicity: An update. Can Anaesth Soc J 1984; 31: (suppl) S16-S22.
14. Okuda A, Kanehisa J, Heersche JN: The effects of sodium fluoride on the resorptive activity of isolated osteoclasts. J Bone Miner Res 1990; 5: (suppl 1) S115-S120.
15. Partanen S: Alkaline fixation-resistant acid phosphatases in human tissues: Histochemical evidence for a new type of acid phosphatase in endothelial, endometrial and neuronal sites. Histochem J 2001; 33: 387-395.
16. Permentier De PJ, Rost FWD: Histochemical and biochemical studies of the kinetics of non-specific phosphatase in rat kidney. Eur J Histochem 1994; 38: 137-144.
17. Pinkse MWH, Merkx M, Averill BA: Fluoride inhibition of bovine spleen purple acid phosphatase: Characterization of a ternary enzyme-phosphatae-fluoride complex as a model for the active enzyme-substrate-hydroxide complex. Biochemistry 1999; 38: 9926-9936.
18. Plummer JL, Hall PD, Jenner MA, et al.: Hepatic and renal effects of prolonged exposure of rats to 50 p.p.m. methoxyflurane. Acta Pharmacol Toxicol (Copenh) 1985;57:176-183.
19. Suter A, Everts V, Boyde A, et al.: Overlapping functions of lysosomal acid phosphatase (LAP) and tartrate-resistant acid phosphatase (Acp5) revealed by doubly deficient mice. Development 2001; 128: 4899-4910.
20. Thomas AB, Hashimoto H, Baylink DJ, et al.: Fluoride at mitogenic concentrations increases the steady state phosphotyrosyl phosphorylation level of cellular proteins in human bone cells. J Clin Endocrinol Metab 1996; 81: 2570-2578.
21. Van Noorden CJF, Butcher, RG: Quantitative enzyme histochemistry. In: Stoward PJ, Pearse AGE (eds): Histochemistry. Theoretical and Applied Fourth Edition. Vol 3. Enzyme Histochemistry. Churchill Livingstone London 1991: 355-432.
22. Wang P, Verin AD, Birukova A, et al.: Mechanisms of sodium fluoride-induced endothelial cell barrier dysfunction: Role of MLC phosphorylation. Am J Physiol Lung Cell Mol Physiol 2001; 281: L1472-L1483.
23. Wergedal JE, Lau KH: Human bone cells contain a fluoride sensitive acid phosphatase: Evidence that this enzyme functions at neutral pH as a phosphotyrosyl protein phosphatase. Clin Biochem 1992; 25: 47-53.
24. Yoshida C, Shah H, Weinhouse S: Purification and properties of inorganic pyrophosphatase of rat liver and hepatoma 3924A. Cancer Res 1982; 42: 3526-3531.
25. Zager RA, Iwata M: Inorganic fluoride. Divergent effects on human proximal tubular cell viability. Am J Pathol 1997; 150: 735-745.